US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

SYRS Syros Pharmaceuticals Inc

0.2751

0.0151 (5.81%)

22 Nov 2024 - Cerrado

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jason Haas

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Syros Pharmaceuticals (NASDAQ:SYRS)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

Haga Click aquí para más Gráficas Syros Pharmaceuticals.

Syros Pharmaceuticals (NASDAQ:SYRS)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024

Haga Click aquí para más Gráficas Syros Pharmaceuticals.

Noticias sobre Syros Pharmaceuticals Inc SYRS

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 20 de Noviembre 2024 (3 días hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 20 de Noviembre 2024 (3 días hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 20 de Noviembre 2024 (3 días hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Miércoles 20 de Noviembre 2024 (3 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 18 de Noviembre 2024 (5 días hace) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jueves 14 de Noviembre 2024 (1 semana hace) • Edgar (US Regulatory)

Más de Syros Pharmaceuticals Inc Artículos de Noticias

Gold vs US Dollar

Euro vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones